Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Date & Meeting Presentation pdf file

January 2005,
WHO Residential Risk Project, Geneva

 

Economic analysis and radon remediation
A. Gray.

 

Link to file

 

January 2005, Health Economists' Study Group, Oxford

Estimating care costs from observational data: acute costs of stroke in the UK NHS 2002-2004. Ramon Luengo-Fernandez, Alastair Gray

Not available

 

January 2005, Health Economists' Study Group, Oxford

 

 

Making Difficult Choices. Are health care resources being deployed according to the principles of cost-effectiveness. Jane Wolstenholme, Ramon Luengo-Fernandez, Jose Leal, Alastair Gray.

Not available

 

 

January 2005, Health Economists' Study Group, Oxford

 

The cost-effectiveness of DNA testing for sudden cardiac death syndrome. Sarah Wordsworth, Jose Leal, Rosa Legood.

Not available

 

March 2005, Second International Conference on Infant Development in Neonatal Intensive Care. London.

 

Measuring cost-effectiveness of early intervention in the NICU.
Stavros Petrou (invited guest lecture)

 

Not available

 

 

May 2005, Research and Development Seminar, RCN Institute, Oxford

 

Incorporation of health economics evidence into clinical practice guidelines - past and present
J. Simon.

 

Not available

 

 

May 2005, New York Hospital for Bone and Joint Diseases, New York

 

 

What is a clinically significant change? Values reported for the Roland Morris Questionnaire, the Oswestry Disability Index and the Short form - 36. H. Campbell.

 

Not available

 

 

May 2005, International Society for the Study of the Lumbar Spine, New York.

 

 

 

A trial-based cost-utility analysis comparing surgical stabilisation of the spine with a programme of intensive rehabilitation for the treatment of chronic low back pain.
H. Campbell.

 

Not available

 

 

 

May 2005, NOWGEN

 

Is genetic testing for SCD Cost-effectiveness? Sarah Wordsworth

 

Not available

 

May 2005, 10th International Congress of the International Society for Pharmacoeconomics and Outcomes Research, Washington.

 

Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease. A. Briggs, H.Wang, Y.Gagnon, S.Spencer, G.Bale, M.Spencer, S.Burge.

 

Not available

 

 

 

June 2005, MRC Biostatistics Unit, Cambridge

 

 

 

Approaches to subgroup economic analyses in clinical trials - the case of cardiovascular disease prevention.
B. Mihaylova, Dr A. Briggs.

 

Not available

 

 

June 2005, 3rd Annual Research Conference of the Thames Valley Cancer Research Network

 

 

 

Trial and model based methods for assessing the cost-effectiveness of adjuvant chemotherapy for early breast cancer patients.
H. Campbell.

 

Not available

 

 

 

July 2005, iHEA, Barcelona

 

 

 

 

 

 

(1) Modeling lifetime healthcare costs: Insights from Australian individual health expenditure data.
(2) Methodological and empirical issues in modeling health outcomes of treatments for chronic disease across countries.
P. Clarke (oral presentations)

 

Not available

 

 

 

 

July 2005, Spanish Health Economics Conference (AES), Barcelona

 

Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea. (Best oral presentation award). Oliver Rivero-Arias.

 

Not available

 

July 2005, iHEA, Barcelona

 

 

 

Measuring relative price inflation in the UK National Health Service.
A. Gray (oral presentation)

 

Not available

 

 

July 2005, iHEA, Barcelona

 

 

 

The Economic Burden of Cardiovascular Disease in the Enlarged European Union.
Jose Leal, Ramon Luengo-Fernandez, Alastair Gray (Poster)

 

Not available

 

 

July 2005, iHEA, Barcelona

 

 

 

Cost-effectiveness analysis alongside cluster randomised trials: evaluating cervical cancer prevention in rural India.
Rosa Legood (Poster)

 

Not available

 

 

July 2005, iHEA, Barcelona

 

 

 

Making Difficult Choices: Are health care resources being deployed according to the principles of cost-effectiveness?
Ramon Luengo-Fernandez, Jose Leal, Jane Wolstenholme, Alastair Gray (Poster)

 

Not available

 

 

 

July 2005, iHEA, Barcelona

 

 

 

 

 

Analysing and reporting resource-use and outcome measures in multi-country studies: a comparison of methods using data from a large randomised trial.
Oliver Rivero-Arias, Jane Wolstenholme and Alastair Gray (Poster)

 

Not available

 

 

 

July 2005, iHEA, Barcelona

 

 

 

The use of long-term outcome measures in economic evaluations alongside perinatal trials. Judit Simon, Stavros Petrou, Alastair Gray (Poster)

 

Not available

 

 

Health Economists Study Group Meeting, Newcastle, July 2005.

 

Elicting expert opinion in economic models: can we do better? José Leal, Sarah Wordsworth, Rosa Legood

 

Not available

 

 

July 2005, iHEA, Barcelona

 

 

 

 

Economic evaluation and decision making in cardiology: what can genetic technologies add? Sarah Wordsworth, José Leal, Rosa Legood (oral presentation)

 

Not available

 

 

 

July 2005, iHEA, Barcelona

 

 

 

An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothesised preferences in a general population.
Stavros Petrou (oral presentation)

 

Not available

 

 

July 2005, iHEA, Barcelona

 

 

 

Decision modelling for the cost-effectiveness of different strategies for the prevention of Group B Streptococcal Disease in infants.
Liz Schroeder, Stavros Petrou (poster)

 

Not available

 

 

July 2005, iHEA,Barcelona

 

 

 

 

 

 

Economic analysis of preventive interventions - impact of multivariate baseline risk and timeframe of analysis.
Borislava Mihaylova, Andrew Briggs, Alastair Gray on behalf of the Heart Protection Study Collaborative group (oral presentation)

 

Not available

 

 

 

 

July 2005, iHEA,Barcelona

 

 

 

 

 

Approaches to subgroup economic analyses in clinical trials- the case
of cardiovascular disease prevention, Borislava Mihaylova, Andrew Briggs, Alastair Gray on behalf of the Heart Protection Study
Collaborative Group (poster presentation)

 

Not available

 

 

 

July 2005, Guest Lecture at Advanced Methods of Cost-Effectiveness Course, Oxford.

 

The MASS Study: The effectiveness and cost-effectiveness of screening for Abdominal Aortic Aneurysm. H. Campbell.

Not available

 

 

September 2005, University of Leicester

 

 

Advantages of individual patient data.
B Mihaylova, A. Briggs
as part of the Consensus Working Group on the use of evidence in economic decision models.

 

Not available

 

 

October 2005, NCRI cancer conference

 

The economics of cancer screening. Jane Wolstenholme.

 

Not available

 

November 2005, University of Sydney

 

Is genetic testing for HCM cost-effectiveness? Sarah Wordsworth

 

Not available

 

November 2005, American Heart Association meeting, Dallas, Texas, USA

 

 

 

 

 

 

 

Simvastatin in 20,536 People at Different Levels of Vascular Disease
Risk Based on US Costs: Randomised Placebo-Controlled Trial.
Borislava Mihaylova, Jane Armitage, Andrew Briggs, Alastair Gray, Sarah Parish, Rory Collins, University of Oxford, on
behalf of the Heart Protection Study Collaborative Group;